Pioneering GLP-1 Research
The first decentralized science DAO tackling the future of metabolic health
GLP-1 agonists like Ozempic and Mounjaro are the fastest-growing drug class globally, with projected combined sales of $129B+ by 2029. Yet, challenges remain—such as enhancing weight-loss efficacy beyond 20% and addressing muscle loss concerns.
Join us in revolutionizing obesity and diabetes treatment through community-driven research.
🗳️ Direct Impact
Shape research priorities and funding decisions with GLP1 tokens
🧬 Research First
Community-driven research initiatives focused on metabolic health
💡 Shared Success
The community benefits directly from valuable research IP and breakthroughs
GLP1 Token Details
Every day you don't buy GLP1 is another day someone else funds groundbreaking research without you

Research Initiatives
First study funded! Research begins Jan 2025
FUNDED
Fat Mouse Study
Science

Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood sugar, appetite, and digestion. It is a hormone your body naturally produces and it can act like a master switch for metabolic health.
Join Our Community
Note: a minimum balance of 100,000 GLP1 is required to join the token holder TG